Turnaround at TEG 17/03/2010
Organic composting specialist TEG Group is pursuing long-term contracts after turning £1.6 million annual losses into £155,000 pre-tax profits.
Identification technology specialist RCG Holdings has doubled interim profits to £12.1 million pre-tax and extended its Asian reach.
Hong Kong-based RCG, a leading global provider of integrated biometrics and radio frequency identification (RFID) innovations, increased turnover 71 per cent to £38.7 million in the six months to June in the fast-growing security market. The AIM-quoted company launched several new products, including the BioMirage and the FxSecure Key, and raised £41.7 million at 131p in March for ‘mergers, acquisitions, research and development’.
During the first half-year, RCG commissioned a regional head office in Malaysia, opened a Thailand office and ‘secured important channels’ into the Chinese mass market through collaboration with Digital China and various distribution and technological alliances. Executive chairman Dr Raymond Chu highlights the introduction of new ‘niche RFID applications delivered in the high-value areas of anti-counterfeiting and financial industries’.
He promises a continuation of the company’s ‘aggressive growth strategy’ during the rest of 2007. In the second half-year RCG plans to release newer versions of its access control devices and a Microsoft Vista version of the popular FxGuard Windows log-on.
Floated at 10p three years ago by Investec and recommended by Growth Company Investor soon afterwards at 12p and again at 33.5p in 2005, RCG shares hit 152.25p in March. They now trade at 109p, up 4.5p this morning, valuing the company at £253 million.
Partial profit taking looks prudent. However, it could pay to hold on to a chunk for potential future growth.
£7,277 That’s what you would have in your portfolio if you had invested £6,000 into the six Company Watch recommendations in our April 2009 issue.
Advertisement
Growth Company Investor, in association with the London Stock Exchange, presents the most wide-ranging and detailed examination of the AIM market: AIM in Review 2010. For more information and to order, click here or contact our marketing team on 020 7250 7056.
The report reveals the top-earning chief executives and remuneration levels at AIM's most profitable and fastest-growing companies. It also examines constituent parts, including basic salary, bonus, pensions, benefits and share-based payments. To order click here.
Free access to the latest AIM stock recommendations and news from the award-winning Growth Company Investor team. Receive our tips on what stocks to buy direct to your inbox every Tuesday and Friday. Find out more today.
Cautious? Positive? Adventurous? Choose between three levels of risk for a fund of funds from Sharefunds, our sister company. Click here for more information.
The brand new, fully updated AIM Guide 2009/2010 is now available to purchase. AIM Guide is the only fully comprehensive guide to AIM and is regarded as 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today and benefit from a £10 discount!
This report's principal aim is to provide business owners seeking funding with information about the amount of funds that VCTs have to invest. Click here for more information.
Business XL, the award-winning monthly magazine for growing companies, is delighted to announce the launch of a new study on cash shells. The research provides a comprehensive overview of cash shells on AIM, companies that have become a significant feature on the AIM landscape. Buy the Cash Shells 2009 Research Report today or email Halid Delkic to obtain a free two-page abstract.
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
Advertisement
Organic composting specialist TEG Group is pursuing long-term contracts after turning £1.6 million annual losses into £155,000 pre-tax profits.
Bid candidate Cyprotex is moving its drug discovery services into toxicology after pre-tax profits down 15 per cent to £460,413.
Forte Energy expects new uranium resource figures for its Mauritanian projects shortly and could start producing from Guinea by 2012.